3 High Growth Companies With Significant Insider Ownership On Euronext Paris

In This Article:

The French market has been experiencing robust gains, with the CAC 40 Index advancing by 2.48% amid growing hopes for interest rate cuts. This positive economic sentiment provides a fertile ground for growth companies, particularly those with significant insider ownership, which often signals strong confidence in the business's future prospects. When evaluating stocks in such a favorable market environment, it's crucial to consider companies that not only exhibit high growth potential but also have substantial insider ownership. This combination can indicate alignment between management and shareholder interests, potentially leading to more prudent and strategic decision-making.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

24.8%

36%

VusionGroup (ENXTPA:VU)

13.4%

25.7%

Adocia (ENXTPA:ADOC)

11.9%

63%

Icape Holding (ENXTPA:ALICA)

30.2%

35.1%

Arcure (ENXTPA:ALCUR)

21.4%

27.5%

La Fran?aise de l'Energie (ENXTPA:FDE)

19.9%

31.9%

S.M.A.I.O (ENXTPA:ALSMA)

17.3%

35.2%

Munic (ENXTPA:ALMUN)

29.2%

149.2%

OSE Immunotherapeutics (ENXTPA:OSE)

25.6%

5.9%

MedinCell (ENXTPA:MEDCL)

15.8%

71.1%

Click here to see the full list of 23 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas, with a market cap of €511.36 million.

Operations: MedinCell's revenue primarily comes from its pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 15.8%

Earnings Growth Forecast: 71.1% p.a.

MedinCell, a French growth company with high insider ownership, is expected to see substantial revenue growth at 44.7% per year, significantly outpacing the French market's 5.8%. Despite reporting a net loss of €25.04 million for the fiscal year ending March 31, 2024, down from €32.01 million the previous year, MedinCell's earnings are forecasted to grow by 71.06% annually and become profitable within three years. The stock trades at an estimated fair value discount of 87.2%.

ENXTPA:MEDCL Ownership Breakdown as at Aug 2024
ENXTPA:MEDCL Ownership Breakdown as at Aug 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. offers public and private cloud services, shared hosting, and dedicated server solutions globally, with a market cap of €1.12 billion.